Lassere M, Boers M, van der Heijde D, Boonen A, Edmonds J, Saudan A, Verhoeven A C
Department of Rheumatology, St. George Hospital, Sydney, NSW, Australia.
J Rheumatol. 1999 Mar;26(3):731-9.
Omeract IV started a discussion on the development of radiological response criteria in rheumatoid arthritis (RA). Such criteria depend on the definition of what constitutes the minimum clinically important progression of damage. Because such a definition is currently not available, as a first step we have used the concept of random measurement error to determine what is the smallest detectable difference (SDD) in radiological progression between 2 radiographs of a particular patient. Baseline and 12 month radiographs (hands, wrists, feet) of 52 patients representative of the spectrum of radiological progression were selected from a randomized controlled trial of early rheumatoid arthritis (COBRA study) and were read paired and chronologically by 2 observers using the van der Heijde modified Sharp method (0-448 scale) and another 2 observers using the Scott modified Larsen method (0-200). The measurement error of progression was determined using the metric 95% limits of agreement method of Bland and Altman. In the setting of early RA the SDD is 11 modified Sharp score units and 8 modified Larsen score units if there is an equal distribution of baseline damage and progression in the sample and the mean score of the same trained observers is always used. The SDD is 15.5 modified Sharp score units and 11 modified Larsen score units if there is an equal distribution of baseline damage and progression in the sample and the mean score of any 2 trained observers is used. Other SDD were determined depending on the context of measurement. Although this exercise needs repetition in other settings, the SDD is a useful starting point in the development of radiological response criteria.
OMERACT IV启动了关于类风湿关节炎(RA)放射学反应标准制定的讨论。此类标准取决于对构成损害最小临床重要进展的定义。由于目前尚无这样的定义,作为第一步,我们使用随机测量误差的概念来确定特定患者的两张X光片之间放射学进展中最小可检测差异(SDD)。从早期类风湿关节炎的一项随机对照试验(COBRA研究)中选取了52例代表放射学进展范围的患者的基线和12个月时的X光片(手、腕、足),由2名观察者使用范德海伊德改良Sharp方法(0 - 448分制)进行配对并按时间顺序读取,另外2名观察者使用斯科特改良Larsen方法(0 - 200分制)进行读取。使用Bland和Altman的一致性界限95%方法确定进展的测量误差。在早期RA的情况下,如果样本中基线损害和进展分布均匀且始终使用同一组经过培训的观察者的平均分,则SDD为11个改良Sharp评分单位和8个改良Larsen评分单位。如果样本中基线损害和进展分布均匀且使用任意2名经过培训的观察者的平均分,则SDD为15.5个改良Sharp评分单位和11个改良Larsen评分单位。根据测量背景确定了其他SDD。尽管此操作需要在其他环境中重复,但SDD是制定放射学反应标准的一个有用起点。